Cargando…
Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3
BACKGROUND: Antibody resistance, not only de novo but also acquired cases, usually exists and is related with lower survival rate and high risk of recurrence. Reversing the resistance often results in better clinical therapeutic effect. Previously, we established a trastuzumab-resistant ovarian canc...
Autores principales: | Wang, Wei, Zhang, Yan, Lv, Ming, Feng, Jiannan, Peng, Hui, Geng, Jing, Lin, Zhou, Zhou, Tingting, Li, Xinying, Shen, Beifen, Ma, Yuanfang, Qiao, Chunxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260252/ https://www.ncbi.nlm.nih.gov/pubmed/25424625 http://dx.doi.org/10.1186/s13048-014-0103-5 |
Ejemplares similares
-
Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation
por: Qiao, Chunxia, et al.
Publicado: (2012) -
SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab-resistant ovarian cancer model
por: Su, Feng, et al.
Publicado: (2017) -
Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against Staphylococcus aureus Infection
por: Liu, Fangjie, et al.
Publicado: (2021) -
Arg9 facilitates the translocation and downstream signal inhibition of an anti-HER2 single chain antibody
por: Hu, Yi, et al.
Publicado: (2012) -
Anti-Axl monoclonal antibodies attenuate the migration of MDA-MB-231 breast cancer cells
por: Chang, Hong, et al.
Publicado: (2021)